NEWARK BETH ISRAEL MEDICAL CENTER — History
CCN 310002 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$670M
Latest Revenue (FY2022)
+13.2%
Revenue CAGR (3yr)
-9.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $523M | $605M | $670M | +10.7% | +13.2% |
| Operating Expenses | $632M | $689M | $731M | +6.1% | +7.5% |
| Operating Margin | -20.9% | -13.8% | -9.1% | +34.1% | +0.0% |
| Net Income | $-109M | $-84M | $-61M | +27.1% | +0.0% |
| Licensed Beds | 422 | 425 | 422 | -0.7% | +0.0% |
| Total Patient Days | 106,283 | 111,808 | 112,538 | +0.7% | +2.9% |
| Medicare Day % | 17% | 16% | 14% | -14.2% | -9.4% |
| Medicaid Day % | 14% | 10% | 11% | +13.6% | -9.5% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +28.2% ($523M → $670M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+13.2%
This Hospital
+7.6%
State Avg
Latest Margin
-9.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $743M | -3.2% |
| FY2024 (proj) | $817M | 2.7% |
| FY2025 (proj) | $891M | 8.6% |